High Sensitivity C-reactive Protein: An Emerging Role in Cardiovascular Risk Assessment

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Critical reviews in clinical laboratory sciences

• Publication date

  2002-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/10408360290795556PMID 12385503
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Soluble P-Selectin and the Risk of Future Cardiovascular Events

  2001cited by this paper
• Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects.

  2001cited by this paper
• Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults.

  2001cited by this paper
• C-Reactive Protein–Mediated Low Density Lipoprotein Uptake by Macrophages: Implications for Atherosclerosis

  2001cited by this paper
• Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events.

  2001cited by this paper
• Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study.

  2001cited by this paper
• C-Reactive Protein in Ischemic Stroke: An Independent Prognostic Factor

  2001cited by this paper
• Rapid Reduction in C-Reactive Protein With Cerivastatin Among 785 Patients With Primary Hypercholesterolemia

  2001cited by this paper
• Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis

  2001cited by this paper
• A major role for VCAM-1, but not ICAM-1, in early atherosclerosis.

  2001cited by this paper
• The pravastatin inflammation CRP evaluation (PRINCE): rationale and design.

  2001cited by this paper
• Role of novel markers of inflammation in patients with stable coronary heart disease.

  2001cited by this paper
• Effect of Hydroxymethyl Glutaryl Coenzyme A Reductase Inhibitor Therapy on High Sensitive C-Reactive Protein Levels

  2001cited by this paper
• An HMG-CoA Reductase Inhibitor, Cerivastatin, Suppresses Growth of Macrophages Expressing Matrix Metalloproteinases and Tissue Factor In Vivo and In Vitro

  2001cited by this paper
• Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris

  2001cited by this paper
• Modulation of C-Reactive Protein-Mediated Monocyte Chemoattractant Protein-1 Induction in Human Endothelial Cells by Anti-Atherosclerosis Drugs

  2001cited by this paper
• Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris. OPUS-TIMI 16 Investigators.

  2001cited by this paper
• Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease.

  2001cited by this paper
• [Inflammation and acute coronary syndromes].

  2001cited by this paper
• Proposed cardiovascular risk assessment algorithm using high-sensitivity C-reactive protein and lipid screening.

  2001cited by this paper
• Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2.

  2001cited by this paper
• Blood Rheology, Cardiovascular Risk Factors, and Cardiovascular Disease: The West of Scotland Coronary Prevention Study

  2000cited by this paper
• Simvastatin Has Anti-Inflammatory and Antiatherosclerotic Activities Independent of Plasma Cholesterol Lowering

  2000cited by this paper
• Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.

  2000cited by this paper
• Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells

  2000cited by this paper
• Development and validation of an automated and ultrasensitive immunoturbidimetric assay for C-reactive protein.

  2000cited by this paper
• Relationship of Chlamydia pneumoniae infection to severity of human coronary atherosclerosis.

  2000cited by this paper
• C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.

  2000cited by this paper
• Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction.

  2000cited by this paper
• C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men.

  2000cited by this paper
• Plasma concentration of soluble vascular cell adhesion molecule-1 and subsequent cardiovascular risk.

  2000cited by this paper
• Infections, inflammation, and the risk of coronary heart disease.

  2000cited by this paper
• Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses

  2000cited by this paper
• Evaluation of four automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications.

  2000cited by this paper
• Plasma levels of C-reactive protein after coronary stent implantation.

  2000cited by this paper
• Prognostic value of C-reactive protein levels within six hours after the onset of acute myocardial infarction.

  2000cited by this paper
• Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease.

  2000cited by this paper
• Serum amyloid A predicts early mortality in acute coronary syndromes: A TIMI 11A substudy.

  2000cited by this paper
• Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

  2000cited by this paper
• The New England Journal

  2000cited by this paper
• Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and type 2 diabetic patients.

  2000cited by this paper
• Inflammation and Acute Coronary Syndromes

  2000cited by this paper
• Predictive value of C-reactive protein and troponin T in patients with unstable angina: A comparative analysis

  2000cited by this paper
• Leukocyte counts and concentrations of soluble adhesion molecules as predictors of coronary atherosclerosis

  2000cited by this paper
• Elevated levels of homocysteine increase IL-6 production in monocytic Mono Mac 6 cells.

  2000cited by this paper
• Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial.

  2000cited by this paper
• Coronary Events With Lipid-Lowering Therapy: The AFCAPS/TexCAPS Trial

  1999cited by this paper
• Hormone replacement therapy and increased plasma concentration of C-reactive protein.

  1999cited by this paper
• Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study.

  1999cited by this paper
• Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty.

  1999cited by this paper
• A prospective study of fibrinogen and risk of myocardial infarction in the Physicians' Health Study.

  1999cited by this paper
• Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein

  1999cited by this paper
• Increased C-reactive Protein Levels during Short-term Hormone Replacement Therapy in Healthy Postmenopausal Women

  1999cited by this paper
• Atherosclerosis--an inflammatory disease.

  1999cited by this paper
• Independent prognostic value of C-reactive protein and troponin I in patients with unstable angina or non-Q-wave myocardial infarction.

  1999cited by this paper
• C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992.

  1999cited by this paper
• Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability.

  1999cited by this paper
• Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques.

  1999cited by this paper
• Hormone replacement therapy, inflammation, and hemostasis in elderly women.

  1999cited by this paper
• Elevated levels of C-reactive protein before coronary artery bypass grafting predict recurrence of ischemic events.

  1999cited by this paper
• Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention Study.

  1999cited by this paper
• Role of inflammation in the pathogenesis of unstable coronary artery diseases.

  1999cited by this paper
• Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators.

  1999cited by this paper
• Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly.

  1999cited by this paper
• Evaluation of serum levels of solubilized adhesion molecules and cytokine receptors in coronary heart disease.

  1999cited by this paper
• Lipid lowering and beyond: Results from the CARE study on lipoproteins and inflammation

  1999cited by this paper
• Complement and atherogenesis: binding of CRP to degraded, nonoxidized LDL enhances complement activation.

  1999cited by this paper
• Baseline IgG Antibody Titers to Chlamydia pneumoniae, Helicobacter pylori, Herpes Simplex Virus, and Cytomegalovirus and the Risk for Cardiovascular Disease in Women

  1999cited by this paper
• Atherosclerosis is an inflammatory disease.

  1999cited by this paper
• Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction.

  1999cited by this paper
• A new method of measuring C-reactive protein, with a low limit of detection, suitable for risk assessment of coronary heart disease.

  1999cited by this paper
• Independent prognostic value of elevated C-reactive protein in unstable angina.

  1999cited by this paper
• C-Reactive Protein Is a Potent Predictor of Mortality Independently of and in Combination With Troponin T in Acute Coronary Syndromes: A TIMI 11A Substudy

  1998cited by this paper
• C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries.

  1998cited by this paper
• Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies.

  1998cited by this paper
• Incremental prognostic value of serum levels of troponin T and C-reactive protein on admission in patients with unstable angina pectoris.

  1998cited by this paper
• C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction.

  1998cited by this paper
• Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction.

  1998cited by this paper
• Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease.

  1998cited by this paper
• Complement C6 deficiency protects against diet-induced atherosclerosis in rabbits.

  1998cited by this paper
• Vascular damage from smoking: disease mechanisms at the arterial wall

  1998cited by this paper
• Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trial.

  1998cited by this paper
• Rapid automated high sensitivity enzyme immunoassay of C-reactive protein.

  1998cited by this paper
• Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men.

  1998cited by this paper
• C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction.

  1998cited by this paper
• Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

  1998cited by this paper
• Atherogenic properties of enzymatically degraded LDL: selective induction of MCP-1 and cytotoxic effects on human macrophages.

  1998cited by this paper
• Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

  1998cited by this paper
• The first subcomponent of complement, C1q, triggers the production of IL-8, IL-6, and monocyte chemoattractant peptide-1 by human umbilical vein endothelial cells.

  1998cited by this paper
• Analytical Evaluation of Particle-Enhanced Immunonephelometric Assays for C-Reactive Protein, Serum Amyloid a and Mannose-Binding Protein in Human Serum

  1998cited by this paper
• Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke.

  1998cited by this paper
• Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys.

  1998cited by this paper
• Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.

  1997cited by this paper
• New indices of ischemic heart disease and aging: studies on the serum levels of soluble intercellular adhesion molecule-1 (ICAM-1) and soluble vascular cell adhesion molecule-1 (VCAM-1) in patients with hypercholesterolemia and ischemic heart disease.

  1997cited by this paper
• Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project.

  1997cited by this paper
• HMG-CoA reductase inhibitors: a new class of anti-inflammatory drugs?

  1997cited by this paper
• C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction.

  1997cited by this paper
• Immunohistochemical colocalization of the terminal complex of human complement and smooth muscle cell alpha-actin in early atherosclerotic lesions.

  1997cited by this paper
• Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications.

  1997cited by this paper
• Low Density Lipoprotein Oxidation and Its Pathobiological Significance*

  1997cited by this paper

• A colorimetric paper-based immunosensor for high-sensitivity C-reactive protein (hs-CRP) detection.

  2026cites this paper
• The Prognostic Value of hsCRP in CVD/CKD Among East Asian Population

  2025cites this paper
• Preventing Premature Coronary Artery Disease: The Synergistic Role of Biomarker Screening and Physical Activity.

  2025cites this paper
• Risk Factors and VEGF, hs-CRP, and ESR in Central Serous Chorioretinopathy

  2024cites this paper
• Cerium oxide nanoparticles impact on sepsis-induced cerebral injury: Deciphering miRNA / NF-κB/TLR signalling pathway.

  2024cites this paper
• Leukocyte ratios in non-diabetic hypertensive Cameroonians do not predict cardiovascular risk : preliminary results of the HYRICCA project

  2023cites this paper
• Effect of periodontal treatment on reducing chronic inflammation in systemically healthy patients with periodontal disease: a multicenter study.

  2023cites this paper
• Thymoquinone modulates the expression of sepsis-related microRNAs in a CLP model

  2022cites this paper
• Association between serum level of C-reactive protein and risk of cardiovascular events based on cohort studies

  2021cites this paper
• Microbes and Infectious Diseases

  2021cites this paper
• Neutrophil-to-lymphocyte ratio in patients with white-coat hypertension

  2021cites this paper
• Haematological & Inflammatory Markers in Septicaemia and Its Prognostic Implications in Okhla Industrial Area

  2021cites this paper
• Radiography and ct features of atherosclerosis in two miniature schnauzer dogs

  2020cites this paper
• COMPARATIVE RESEARCH TO ASSESS THE LEVEL OF C-REACTIVE PROTEIN (CRP) AMONG SMOKERS AND NON-SMOKERS DIAGNOSED WITH CHRONIC PERIODONTITIS

  2019cites this paper
• Thymoquinone reduces mortality and suppresses early acute inflammatory markers of sepsis in a mouse model.

  2018cites this paper
• The Use of Biomarkers in Sepsis: A Systematic Review.

  2017cites this paper
• Single Frequency Impedance Analysis on Reduced Graphene Oxide Screen-Printed Electrode for Biomolecular Detection

  2017cites this paper
• The Anti-Inflammatory Effects of the Dietary Dipeptide, Gamma-Glutamylvaline in a Mouse Model of LPS-Induced Sepsis

  2016cites this paper
• High performance dendrimer functionalized single-walled carbon nanotubes field effect transistor biosensor for protein detection

  2016cites this paper
• The Anti-Inflammatory Effects of the Dietary Dipeptide , Gamma-Glutamylvaline in a Mouse Model of LPS-Induced Sepsis

  2016cites this paper
• C‐reactive Protein: Repeated Measurements will Improve Dialysis Patient Care

  2016cites this paper
• Conventional, molecular methods and biomarkers molecules in detection of septicemia

  2015cites this paper
• SEPSIS BIOMARKERS. PAST, PRESENT AND FUTURE

  2015cites this paper
• EFFECT OF SMOKING ON C-REACTIVE PROTEIN LEVELS IN CHRONIC PERIODONTITIS

  2015cites this paper
• Ultrasensitive Electrochemical Immunosensor Based on Pt Nanoparticle–Graphene Composite

  2014cites this paper
• Risk assessment of post-infarction heart failure. Systematic review on the role of emerging biomarkers

  2014cites this paper
• Ultrasensitive amperometric magnetoimmunosensor for human C-reactive protein quantification in serum

  2013cites this paper
• Biomarkers of sepsis

  2013cites this paper
• Overt and Mild Subclinical Hypothyroidism Do Not Influence Mean Platelet Volume in Premenopausal Women Having Low Cardiac Risk

  2012cites this paper
• Association of high-sensitivity C-reactive protein with cardiometabolic risk factors and micronutrient deficiencies in adults of Ouagadougou, Burkina Faso

  2012cites this paper
• C-Reactive Protein Predicts the Severity of Coronary Artery Disease Beyond Low-Density Lipoprotein Cholesterol

  2012cites this paper
• Effect of enhanced external counterpulsation treatment on mean platelet volume in patients affected by ischemic chronic heart failure

  2012cites this paper
• Évolution du risque cardiométabolique sur une période de quatre ans : Étude chez des adultes béninois

  2012cites this paper
• Lipids, Lipoproteins, Apolipoproteins, and Other Cardiovascular Risk Factors

  2012cites this paper
• The association between chronic stress type and C-reactive protein in the multi-ethnic study of atherosclerosis: does gender make a difference?

  2012cites this paper
• The cardiovascular profile of HIV-infected South Africans of African descent: a 5-year prospective study

  2011cites this paper
• DETECTION OF CRP BASED ON DBR POROUS SILICON INTERFEROMETERS

  2011cites this paper
• Use of Highly Sensitive C-Reactive Protein for Followup of Wegener’s Granulomatosis

  2010cites this paper
• The Association of Low-Grade Systemic Inflammation with Hypertensive Retinopathy

  2010cites this paper
• Granulomatosis Use of Highly Sensitive C-Reactive Protein for Followup of Wegener ' s

  2010cites this paper
• CHANGES IN PLATELET SIZE AND SPLEEN VOLUME IN RESPONSE TO SELECTIVE AND NON‐SELECTIVE β‐ADRENOCEPTOR BLOCKADE IN HYPERTENSIVE PATIENTS

  2009cites this paper
• The effect of subclinical hypothyroidism on platelet parameters

  2009cites this paper
• The effect of rosuvastatin treatment on the mean platelet volume in patients with uncontrolled primary dyslipidemia with hypolipidemic diet treatment

  2008cites this paper
• Cardiovascular biomarkers: increasing impact of laboratory medicine in cardiology practice

  2008cites this paper
• The association of mean platelet volume levels with hypertensive retinopathy

  2008cites this paper
• Platelet activation in subjects with subclinical hypothyroidism.

  2007cites this paper
• Low-grade inflammation in white-coat hypertension.

  2007cites this paper
• The effect of weight loss on the mean platelet volume in obese patients

  2007cites this paper
• La crescente importanza della medicina di laboratorio nella pratica cardiologica: una introduzione

  2007cites this paper
• UNRESOLVED ISSUES IN DIALYSIS: Inflammatory Biomarkers and Cardiovascular Risk: Association or Cause and Effect?

  2006cites this paper
• Measurement of dimensions of pentagonal doughnut-shaped C-reactive protein using an atomic force microscope and a dual polarisation interferometric biosensor.

  2006influential citation
• Rapid electrochemiluminoimmunoassay of human C-reactive protein at planar disposable oxide-coated silicon electrodes.

  2006cites this paper
• Boiled or Filtered Coffee?

  2006cites this paper
• High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors: the Third National Health and Nutrition Examination Survey.

  2005cites this paper
• The mean platelet volume in patients with obesity

  2005cites this paper
• Inflammation in patients with lupus anticoagulant and implications for thrombosis.

  2005cites this paper
• The effect of fenofibrate on the levels of high sensitivity C‐reactive protein in dyslipidaemic hypertensive patients

  2005cites this paper
• The mean platelet volume in patients with essential and white coat hypertension

  2005cites this paper
• Association between LDL-cholesterol, statin therapy, physical activity and inflammatory markers in patients with stable coronary heart disease.

  2005influential citation
• Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort.

  2005cites this paper
• The Levels of Serum High Sensitivity C-reactive Protein in Subjects with Impaired Fasting Glucose

  2004cites this paper
• Coronary slow flow phenomenon: an angiographic curiosity.

  2004cites this paper
• In Vitro Biomarker Discovery for Atherosclerosis by Proteomics*

  2004cites this paper
• The Effect of Fenofibrate on the Levels of High Sensitivity C‐Reactive Protein in Dyslipidemic Obese Patients

  2004cites this paper
• Influence of diabetes on the exacerbation of an inflammatory response in cardiovascular tissue.

  2004cites this paper
• Electrogenerated chemiluminescence. 80. C-reactive protein determination at high amplification with [Ru(bpy)3]2+-containing microspheres.

  2004cites this paper
• Electrochemiluminescence (ECL).

  2004cites this paper
• A dietary pattern derived to explain biomarker variation is strongly associated with the risk of coronary artery disease.

  2004cites this paper
• Gene profiling identifies secreted protein transcripts from peripheral blood cells in coronary artery disease.

  2003cites this paper
• The Increasing Impact of Laboratory Medicine on Clinical Cardiology

  2003cites this paper
• Atherosclerosis and antiphospholipid syndrome

  2003cites this paper
• Electrogenerated chemiluminescence. 72. Determination of immobilized DNA and C-reactive protein on Au(111) electrodes using tris(2,2'-bipyridyl)ruthenium(II) labels.

  2003cites this paper
• Endothelial activation, endothelial dysfunction and premature atherosclerosis in systemic autoimmune diseases.

  2003cites this paper
• Short Communication Gene profiling identifies secreted protein transcripts from peripheral blood cells in coronary artery disease

  2003cites this paper